Related references
Note: Only part of the references are listed.Cytokine storm syndrome in coronavirus disease 2019: A narrative review
Y. -M. Gao et al.
JOURNAL OF INTERNAL MEDICINE (2021)
A new coronavirus associated with human respiratory disease in China
Fan Wu et al.
NATURE (2020)
A pneumonia outbreak associated with a new coronavirus of probable bat origin
Peng Zhou et al.
NATURE (2020)
Why does COVID-19 disproportionately affect older people?
Amber L. Mueller et al.
AGING-US (2020)
Oxidative Stress as Key Player in Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV) Infection
Livan Delgado-Roche et al.
ARCHIVES OF MEDICAL RESEARCH (2020)
Efficacy and safety of corticosteroids in COVID-19 based on evidence for COVID-19, other coronavirus infections, influenza, community-acquired pneumonia and acute respiratory distress syndrome: a systematic review and meta-analysis
Zhikang Ye et al.
CANADIAN MEDICAL ASSOCIATION JOURNAL (2020)
Cytokine storm in COVID-19: pathogenesis and overview of anti-inflammatory agents used in treatment
Mehmet Soy et al.
CLINICAL RHEUMATOLOGY (2020)
Understanding the renin angiotensin-aldosterone-SARS-CoV axis: a comprehensive review
Nicholas E. Ingraham et al.
EUROPEAN RESPIRATORY JOURNAL (2020)
COVID-19: A New Virus, but a Familiar Receptor and Cytokine Release Syndrome
Toshio Hirano et al.
IMMUNITY (2020)
Prevalence of comorbidities and its effects in patients infected with SARS-CoV-2: a systematic review and meta-analysis
Jing Yang et al.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2020)
Old and new antirheumatic drugs for the treatment of COVID-19
Maurizio Benucci et al.
JOINT BONE SPINE (2020)
ACE2 receptor polymorphism: Susceptibility to SARS-CoV-2, hypertension, multi-organ failure, and COVID-19 disease outcome
Christian A. Devaux et al.
JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION (2020)
Acute kidney injury in patients hospitalized with COVID-19
Jamie S. Hirsch et al.
KIDNEY INTERNATIONAL (2020)
Trials of anti-tumour necrosis factor therapy for COVID-19 are urgently needed
Marc Feldmann et al.
LANCET (2020)
Sex Hormones and Novel Corona Virus Infectious Disease (COVID-19)
Rasha A. Al-Lami et al.
MAYO CLINIC PROCEEDINGS (2020)
Remdesivir for the Treatment of Covid-19-Final Report
John H. Beigel et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Renal complications in COVID-19: a systematic review and meta-analysis
Setor K. Kunutsor et al.
ANNALS OF MEDICINE (2020)
What is the role of supplementation with ascorbic acid, zinc, vitamin D, or N-acetylcysteine for prevention or treatment of COVID-19?
Seth R. Bauer et al.
CLEVELAND CLINIC JOURNAL OF MEDICINE (2020)
Azithromycin for COVID-19: More Than Just an Antimicrobial?
Nathalie Bleyzac et al.
CLINICAL DRUG INVESTIGATION (2020)
SARS-CoV-2 infection: The role of cytokines in COVID-19 disease
Victor J. Costela-Ruiz et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2020)
COVID 19: a clue from innate immunity
Domenico Birra et al.
IMMUNOLOGIC RESEARCH (2020)
COVID-19 in people with diabetes: understanding the reasons for worse outcomes
Matteo Apicella et al.
LANCET DIABETES & ENDOCRINOLOGY (2020)
Cytokine Storm in COVID-19: The Current Evidence and Treatment Strategies
Yujun Tang et al.
FRONTIERS IN IMMUNOLOGY (2020)
COVID-19 as a STING disorder with delayed over-secretion of interferon-beta
Jean-Marie Berthelot et al.
EBIOMEDICINE (2020)
p38 MAPK inhibition: A promising therapeutic approach for COVID-19
Joseph M. Grimes et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2020)
Thrombotic microangiopathy in a patient with COVID-19
Kenar D. Jhaveri et al.
KIDNEY INTERNATIONAL (2020)
N-acetyl-cysteine may prevent COVID-19-associated cytokine storm and acute respiratory distress syndrome
Stelios F. Assimakopoulos et al.
MEDICAL HYPOTHESES (2020)
STEROID IS FIRST DRUG SHOWN TO PREVENT DEATHS FROM COVID-19
Heidi Ledford
NATURE (2020)
Factors associated with COVID-19-related death using OpenSAFELY
Elizabeth J. Williamson et al.
NATURE (2020)
Unpuzzling COVID-19: tissue-related signaling pathways associated with SARS-CoV-2 infection and transmission
Daniella S. Battagello et al.
CLINICAL SCIENCE (2020)
Taming the cytokine storm: repurposing montelukast for the attenuation and prophylaxis of severe COVID-19 symptoms
Nitesh Sanghai et al.
DRUG DISCOVERY TODAY (2020)
Coronavirus infection (SARS-CoV-2) in obesity and diabetes comorbidities: is heat shock response determinant for the disease complications?
Mauricio Krause et al.
DIABETOLOGY & METABOLIC SYNDROME (2020)
Dexamethasone: A boon for critically ill COVID-19 patients?
Shailesh Kumar Patel et al.
TRAVEL MEDICINE AND INFECTIOUS DISEASE (2020)
Inflammation: A bridge between diabetes and COVID-19, and possible management with sitagliptin
Negin Mozafari et al.
MEDICAL HYPOTHESES (2020)
The Comparative Immunological Characteristics of SARS-CoV, MERS-CoV, and SARS-CoV-2 Coronavirus Infections
Yun-yu Zhang et al.
FRONTIERS IN IMMUNOLOGY (2020)
From SARS and MERS to COVID-19: a brief summary and comparison of severe acute respiratory infections caused by three highly pathogenic human coronaviruses
Zhixing Zhu et al.
RESPIRATORY RESEARCH (2020)
Elevation of plasma angiotensin II level is a potential pathogenesis for the critically ill COVID-19 patients
Zhiyong Wu et al.
CRITICAL CARE (2020)
Immune response in COVID-19: addressing a pharmacological challenge by targeting pathways triggered by SARS-CoV-2
Michele Catanzaro et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2020)
Age and sex differences in soluble ACE2 may give insights for COVID-19
Per Sward et al.
CRITICAL CARE (2020)
Role of corticosteroid in the management of COVID-19: A systemic review and a Clinician's perspective
Awadhesh Kumar Singh et al.
DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS (2020)
NF-κB Signaling in Macrophages: Dynamics, Crosstalk, and Signal Integration
Michael G. Dorrington et al.
FRONTIERS IN IMMUNOLOGY (2019)
The non-canonical NF-κB pathway and its contribution to β-cell failure in diabetes
Kira Meyerovich et al.
JOURNAL OF MOLECULAR ENDOCRINOLOGY (2018)
Pathogenic human coronavirus infections: causes and consequences of cytokine storm and immunopathology
Rudragouda Channappanavar et al.
SEMINARS IN IMMUNOPATHOLOGY (2017)
Inflammation and the Metabolic Syndrome: The Tissue-Specific Functions of NF-κB
Leen Catrysse et al.
TRENDS IN CELL BIOLOGY (2017)
NF-kappa B signaling in inflammation
Ting Liu et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2017)
The non-canonical NF-κB pathway in immunity and inflammation
Shao-Cong Sun
NATURE REVIEWS IMMUNOLOGY (2017)
30 Years of NF-κB: A Blossoming of Relevance to Human Pathobiology
Qian Zhang et al.
CELL (2017)
SARS and MERS: recent insights into emerging coronaviruses
Emmie de Wit et al.
NATURE REVIEWS MICROBIOLOGY (2016)
IFN-α2a or IFN-β1a in combination with ribavirin to treat Middle East respiratory syndrome coronavirus pneumonia: a retrospective study
Sarah Shalhoub et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2015)
Nuclear factor κB-inducing kinase activation as a mechanism of pancreatic β cell failure in obesity
Elisabeth K. Malle et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2015)
Linking Angiotensin II to Nuclear Factor-κ Light Chain Enhancer of Activated B Cells-Induced Cardiovascular Damage Bad CARMAs
Steven D. Crowley
HYPERTENSION (2014)
Inhibition of NF-κB-Mediated Inflammation in Severe Acute Respiratory Syndrome Coronavirus-Infected Mice Increases Survival
Marta L. DeDiego et al.
JOURNAL OF VIROLOGY (2014)
N-acetylcysteine reduces oxidative stress, nuclear factor-κB activity and Cardiomyocyte apoptosis in heart failure
Xiao-Yan Wu et al.
MOLECULAR MEDICINE REPORTS (2014)
Cardiomyocyte NF-kappa B p65 promotes adverse remodelling, apoptosis, and endoplasmic reticulum stress in heart failure
Tariq Hamid et al.
CARDIOVASCULAR RESEARCH (2011)
NF-κB, Inflammation, and Metabolic Disease
Rebecca G. Baker et al.
CELL METABOLISM (2011)
The nuclear factor-kappa B-interleukin-6 signalling pathway mediating vascular inflammation
Allan R. Brasier
CARDIOVASCULAR RESEARCH (2010)
NF-κB in Renal Inflammation
Ana Belen Sanz et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2010)
Anti-inflammatory Activity of Azithromycin as Measured by Its NF-kappa B Inhibitory Activity
Paul S. Cheung et al.
OCULAR IMMUNOLOGY AND INFLAMMATION (2010)
Activation of NF-kB Pathway by Virus Infection Requires Rb Expression
Maria A. Garcia et al.
PLOS ONE (2009)
A new mouse-adapted strain of SARS-CoV as a lethal model for evaluating antiviral agents in vitro and in vivo
Craig W. Day et al.
VIROLOGY (2009)
SARS coronavirus spike protein-induced innate immune response occurs via activation of the NF-κB pathway in human monocyte macrophages in vitro
Susan F. Dosch et al.
VIRUS RESEARCH (2009)
The NF-κB Family of Transcription Factors and Its Regulation
Andrea Oeckinghaus et al.
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2009)
The Nuclear Factor NF-κB Pathway in Inflammation
Toby Lawrence
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2009)
Activation of innate immunity system during aging: NF-kappa B signaling is the molecular culprit of inflamm-aging
Antero Salminen et al.
AGEING RESEARCH REVIEWS (2008)
SARS-coronavirus replication is supported by a reticulovesicular network of modified endoplasmic reticulum
Kevin Knoops et al.
PLOS BIOLOGY (2008)
p38 Mitogen-activated protein kinase inhibition ameliorates angiotensin II-induced target organ damage
Joon-Keun Park et al.
HYPERTENSION (2007)
NF-κB regulation in the immune system
QT Li et al.
NATURE REVIEWS IMMUNOLOGY (2002)
Protein kinase R regulates double-stranded RNA induction of TNF-α but not IL-1β mRNA in human epithelial cells
TR Meusel et al.
JOURNAL OF IMMUNOLOGY (2002)
p38-dependent marking of inflammatory genes for increased NF-kappa B recruitment
S Saccani et al.
NATURE IMMUNOLOGY (2002)
N-acetylcysteine suppresses TNF-induced NF-κB activation through inhibition of IκB kinases
S Oka et al.
FEBS LETTERS (2000)
Share Paper
